Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Q1 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Dec 31, 2015
Assets:
Real estate held for use:
Land
Rental residential properties
Real estate owned
Total real estate held for use
Less: accumulated depreciation
Total real estate held for use, net
Real estate assets held for sale
Mortgage loans at fair value
Mortgage loans held for sale
Cash and cash equivalents
Restricted cash
Accounts receivable
Goodwill
Prepaid expenses and other assets
Total assets
Liabilities:
Other secured borrowings
Repurchase and loan agreements
Accounts payable and accrued liabilities
Payable to AAMC
Total liabilities
Commitments and contingencies (Note 7)
Equity:
Common stock, $0.01 par value, 200,000,000 authorized shares; 58,747,146 shares issued and outstanding as of September 30, 2020 and 53,933,575 shares issued and outstanding as of December 31, 2019
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support